- Home
- IPHA vs RGC Comparison
IPHA vs RGC Comparison
Compare IPHA & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- RGC
- Stock Information
- Founded
- IPHA 1999
- RGC 2014
- Country
- IPHA France
- RGC Hong Kong
- Employees
- IPHA 179
- RGC N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- RGC Medicinal Chemicals and Botanical Products
- Sector
- IPHA Health Care
- RGC Health Care
- Exchange
- IPHA Nasdaq
- RGC Nasdaq
- Market Cap
- IPHA 171.6M
- RGC 171.1M
- IPO Year
- IPHA 2019
- RGC 2021
- Fundamental
- Price
- IPHA $2.12
- RGC $6.59
- Analyst Decision
- IPHA Strong Buy
- RGC
- Analyst Count
- IPHA 1
- RGC 0
- Target Price
- IPHA $11.50
- RGC N/A
- AVG Volume (30 Days)
- IPHA 6.0K
- RGC 26.1K
- Earning Date
- IPHA 09-12-2024
- RGC 10-25-2024
- Dividend Yield
- IPHA N/A
- RGC N/A
- EPS Growth
- IPHA N/A
- RGC N/A
- EPS
- IPHA N/A
- RGC N/A
- Revenue
- IPHA $36,202,722.00
- RGC N/A
- Revenue This Year
- IPHA N/A
- RGC N/A
- Revenue Next Year
- IPHA $105.84
- RGC N/A
- P/E Ratio
- IPHA N/A
- RGC N/A
- Revenue Growth
- IPHA N/A
- RGC N/A
- 52 Week Low
- IPHA $1.81
- RGC $3.03
- 52 Week High
- IPHA $3.15
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- IPHA 42.21
- RGC 46.91
- Support Level
- IPHA $2.22
- RGC $5.05
- Resistance Level
- IPHA $2.35
- RGC $6.57
- Average True Range (ATR)
- IPHA 0.13
- RGC 0.83
- MACD
- IPHA -0.02
- RGC -0.16
- Stochastic Oscillator
- IPHA 5.88
- RGC 42.54
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.